| FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer (NCT07509398) | Shanghai 10th People's Hospital | 2026-04-01 |
| A Phase II Single-arm Clinical Study in the Treatment of Locally Advanced Esophageal Cancer After Failed Neoadjuvant Chemoimmunotherapy (NCT07530549) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-04-01 |
| HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL). (NCT07517510) | Guangdong Second Provincial General Hospital | 2026-04-01 |
| Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults (NCT06811324) | The University of Texas Health Science Center at San Antonio | 2026-04-01 |
| Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital (NCT06834997) | Baylor College of Medicine | 2026-04-01 |
| SMART Trial: Cognitive Sparing Brain Radiotherapy for Multiple Brain Metastases (NCT07505979) | National Taiwan University Hospital | 2026-04-01 |
| Stop Air Leak by Talc or Autologous Blood Patch Therapy (NCT06883188) | Chinese University of Hong Kong | 2026-04-01 |
| NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer (NCT07595172) | West China Hospital | 2026-04-01 |
| CsA+EPAG/HPAG+Romiplostim N01 in Newly-diagnosed SAA/TD-NSAA (NCT07558434) | Peking Union Medical College Hospital | 2026-04-01 |
| Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer (NCT07361133) | National Cancer Institute, Egypt | 2026-04-01 |
| Thumb Base Osteoarthritis: Ultrasound-guided Platelet-rich Plasma Versus Placebo Injection (NCT07491302) | Goed Medisch Centrum | 2026-04-01 |
| Anlotinib and Benmelstobart in DTC (NCT07193186) | Fudan University | 2026-04-01 |
| Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above (NCT07481604) | Aribio Lab Co., Ltd. | 2026-04-01 |
| A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis (NCT07374471) | Mage Biologics | 2026-04-01 |
| Temozolomide Monotherapy or in Combination With Olaparib in Patients With Triple Negative Breast Cancer (TNBC) (NCT05128734) | AHS Cancer Control Alberta | 2026-04-01 |
| Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden (NCT07459920) | National Cancer Institute, Naples | 2026-04-01 |
| Efficacy of Booster Injection With Gardasil-9 Vaccine on Intersurgical Interval* for Adults With Recurrent Respiratory Papillomatosis* (NCT07339163) | Ohio State University | 2026-04-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer (NCT07459738) | Shanghai Henlius Biotech | 2026-04-01 |
| PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia (NCT07454915) | PapiVax Biotech, Inc. | 2026-04-01 |
| CD19/CD22 CAR-T Consolidation in R/R Aggressive B-Cell Lymphoma After Second-Line Therapy (NCT07779018) | Liping Dou | 2026-04-01 |
| Study of Cannabidiol in Sanfilippo Syndrome (NCT06333041) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2026-04-01 |
| Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study (NCT07295821) | AstraZeneca | 2026-04-01 |
| Effects of Dexmedetomidine Versus Ketamine on Inflammatory Response and Hemodynamic in Patients (NCT06490731) | New Valley University | 2026-04-01 |
| Cannabis for the Prophylactic Treatment of Migraine (NCT03972124) | University of Calgary | 2026-04-01 |
| Maralixibat for Intrahepatic Cholestasis of Pregnancy (NCT07389031) | Imperial College London | 2026-04-01 |
| Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke (NCT07501533) | First Affiliated Hospital of Wannan Medical College | 2026-04-01 |
| Postpartum 8-aminoquinoline Breast Milk Study (NCT07060404) | Curtin University | 2026-04-01 |
| Phase 2 Study of BTKi-Rituximab Induction Followed by Glofitamab Consolidation in High Risk Untreated MCL Patients - WINDOW-4 Study (NCT07257055) | M.D. Anderson Cancer Center | 2026-04-01 |
| Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer (NCT07503639) | Fudan University | 2026-04-01 |
| A Trial of Baricitinib in Patients With Cardiac Sarcoidosis (NCT06868381) | Stanford University | 2026-04-01 |
| A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer (NCT07474727) | Multitude Therapeutics Inc. | 2026-04-01 |
| A Phase II Trial Evaluating Radiation Boost to Painful Spinal Metastases (NCT07478289) | Sunnybrook Health Sciences Centre | 2026-04-01 |
| Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML (NCT07026942) | Nationwide Children's Hospital | 2026-04-01 |
| Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo (NCT07519031) | Xijing Hospital | 2026-04-01 |
| A Clinica Study of SCTC21C in Participants With Systemic Lupus Erythematosus (NCT07538154) | Sinocelltech Ltd. | 2026-04-01 |
| Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer (NCT07476677) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-04-01 |
| Prospective, Open-label, Multi-cohort Study of Becotatug Vedotin With Tislelizumab and Chemotherapy in Esophageal Squamous Cell Carcinoma - Phase 2 (NCT07531979) | Tianjin Medical University Cancer Institute and Hospital | 2026-04-01 |
| Belimumab to Mobilise Memory B-cells From Secondary Lymhoid Organs to Improve Memory B-cell HLA-specificity Profiling to Support Delisting for Transplant Access in Highly-sensitized (NCT07539857) | Leiden University Medical Center | 2026-04-01 |
| Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma (NCT07514793) | Fudan University | 2026-04-01 |
| A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency. (NCT07559175) | Aimmune Nestlé Health Science US R&D, LLC | 2026-04-01 |
| A Study of Ivonescimab in People With Leiomyosarcoma (NCT07516925) | Memorial Sloan Kettering Cancer Center | 2026-04-01 |
| Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent Blue V and Indocyanine Green Dyes (NCT07518485) | Centre Hospitalier Universitaire Vaudois | 2026-04-01 |
| Targeting Ischemia-Induced Autophagy Dependence in Hepatocellular Carcinoma (NCT05842174) | VA Office of Research and Development | 2026-04-01 |
| Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC (NCT07519486) | Sichuan University | 2026-04-01 |
| Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis (NCT07527572) | Kaneka Americas Holding Inc. | 2026-04-01 |
| First-In-Human Study of KHN922 for Injection (NCT07514975) | Chengdu Kanghong Biotech Co., Ltd. | 2026-04-01 |
| Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia (NCT07498647) | BioRay Pharmaceutical Co., Ltd. | 2026-04-01 |
| JSKN033 Combination Therapy in Subjects With Advanced Cervical Cancer (NCT07497074) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2026-04-01 |
| Limertinib Plus Radiotherapy for EGFR-Mutant NSCLC With Brain Metastases (NCT07413952) | The First Affiliated Hospital of Guangzhou Medical University | 2026-04-01 |
| GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma (NCT07301268) | Mayo Clinic | 2026-04-01 |
| Adjunctive Fludrocortisone in Septic Shock (NCT07451886) | Chinese University of Hong Kong | 2026-04-01 |
| Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation (NCT07443709) | Oriol Manuel | 2026-04-01 |
| A Multicenter, Single-Arm, Phase II Exploratory Study of Eribulin in Combination With Anlotinib for HER2-Negative Recurrent/Metastatic Breast Cancer Previously Treated With Antibody-Drug Conjugates (NCT07520760) | Sun Yat-sen University | 2026-04-01 |
| GT103 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic STK11 Mutant Non-Small Cell Lung Cancer (NCT07017829) | Roswell Park Cancer Institute | 2026-04-01 |
| A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception (NCT07222228) | Premier Research | 2026-04-01 |
| Study of Efficacy and Safety of NM8074 in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy (NCT05646524) | NovelMed Therapeutics | 2026-04-01 |
| Prophylactic Radiotherapy to Prevent Bone Complications in Patients With Metastatic Solid Cancers (NCT07540650) | Institute of Oncology Ljubljana | 2026-04-01 |
| A Study Comparing the MAGICTouch™ Sirolimus-coated Balloon With a Paclitaxel-coated Balloon for Treating Severe Narrowing or Blockage in the Femoropopliteal Arteries. (NCT07359807) | Concept Medical Inc. | 2026-04-01 |
| Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept (NCT07542678) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2026-04-01 |
| DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. (NCT07440290) | Cancer Research UK | 2026-04-01 |
| Topical 5% Spironolactone Gel Versus 0.1% Adapalene Gel for Acne Vulgaris: A Randomized Split-Face Study (NCT07473895) | Assiut University | 2026-04-01 |
| Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker (NCT07060001) | The Methodist Hospital Research Institute | 2026-04-01 |
| Assessment of Dutasteride Topical Solution in Male Androgenetic Alopecia (NCT07490327) | Moogene Medi Co., Ltd | 2026-04-01 |
| Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma (NCT07517653) | Shanghai Zhongshan Hospital | 2026-04-01 |
| QLS1410 in Participants With Uncontrolled Hypertension (NCT07489612) | Qilu Pharmaceutical Co., Ltd. | 2026-04-01 |
| MB-CART2019.1 in Refractory Multiple Sclerosis (NCT07178431) | Miltenyi Biomedicine GmbH | 2026-04-01 |
| A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy (NCT07412496) | Bausch & Lomb Incorporated | 2026-04-01 |
| Matched Sibling Allogenic Stem Cell Transplantation With Adoptive Immunotherapy With Regulatory And Conventional T Cells For High Risk Acute Myeloid Leukemia (NCT07552649) | Antonio Pierini | 2026-04-01 |
| Evaluation of the Efficacy and Safety of Darolutamide + ADT Combined With Low-dose Docetaxel in mHSPC (NCT07503379) | Yonghong Li | 2026-04-01 |
| A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer (NCT07512076) | Sunnybrook Health Sciences Centre | 2026-04-01 |
| Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults (NCT07369024) | Mohsen Saidinejad | 2026-04-01 |
| Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial (NCT07517640) | Shanghai Pulmonary Hospital, Shanghai, China | 2026-04-01 |
| Research of Traditional Chinese Medicine Oral Preparation of C. Cicadae in the Treatment of ALS Patients With Elevated Plasma Sphingolipids (NCT07467746) | The Third Xiangya Hospital of Central South University | 2026-04-01 |
| Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study (NCT07647016) | Fudan University | 2026-04-01 |
| A Study of LY4515100 in Participants With Pain Following Third Molar Removal (NCT07511816) | Eli Lilly and Company | 2026-04-01 |
| EFFICACY OF ROFLUMILAST IN THE TREATMENT OF FLEXURAL AND/OR GENITAL PSORIASIS: A RANDOMIZED CONTROLLED TRIAL. (NCT07543640) | Eman Raafat Said | 2026-04-01 |
| A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative Bioavailability Via Autoinjector (AI) Versus Syringe Subcutaneously in Participants With Multiple Sclerosis (MS) (NCT07503873) | TG Therapeutics, Inc. | 2026-04-01 |
| To Evaluate Post Operative Pain Using Two Different Kind of Sealers in Obturation of Teeth With Symptomatic Irreversible Pulpitis During Second Visit When the Patient is Painless (NCT07266974) | Jaweria Gul Keyani | 2026-04-01 |
| Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable Hepatocellular Carcinoma (NCT07413354) | Tongji Hospital | 2026-04-01 |
| A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer (NCT07507526) | Sun Yat-sen University | 2026-04-01 |
| Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency (NCT06422351) | Rocket Pharmaceuticals Inc. | 2026-04-01 |
| Precision Microbiota Interventions for Senoreduction Trial (NCT07462767) | Louisiana State University Health Sciences Center in New Orleans | 2026-04-01 |
| Peiyuan Guben Tongluo Ointment for Elderly Sarcopenia (NCT07538674) | Shanghai Yueyang Integrated Medicine Hospital | 2026-04-01 |
| Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma (NCT07477366) | ImmunityBio, Inc. | 2026-04-01 |
| A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients (NCT07185880) | Myosin Therapeutics Inc. | 2026-04-01 |
| Efficacy and Safety of Lifei Qingchang Granules for Stable Bronchiectasis (NCT07523165) | The First Affiliated Hospital of Guangzhou Medical University | 2026-04-01 |
| Biomarker-based Trial of NPC-1 for Alzheimer's Pathology (NCT07236190) | Massachusetts General Hospital | 2026-04-01 |
| Trial of FOLFIRI + Zimberelimab + Domvanalimab vs FOLFIRI With a Hybrid Synthetic Control Arm in Second Line Treatment of Neuroendocrine Carcinoma of Gastro-enteropancreatic or Unknown Origin (REWENEC 01) (NCT07337447) | Hospices Civils de Lyon | 2026-04-01 |
| Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection (NCT07519499) | Zhejiang Kanova Biopharmaceutical Co., LTD | 2026-04-01 |
| Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma (NCT07507916) | Fudan University | 2026-04-01 |
| Cognitive Effects of Bioavailable Curcumin (NCT07251985) | University of California, Los Angeles | 2026-04-01 |
| IIT2025-03-YANG-LIFT-HCC (NCT07489976) | Ju Dong Yang | 2026-04-01 |
| Neoadjuvant Adebrelimab Plus CRT for Locally Advanced Thymic Carcinoma (NCT07479628) | Shanghai Chest Hospital | 2026-04-01 |
| Combining Latency Reversing Agents to Address the HIV Reservoir (NCT07384624) | Erasmus Medical Center | 2026-04-01 |
| Integrating Allogeneic NK Cells in High-risk Advanced Stage III-IV Nasopharyngeal Cancer Patients (NCT07247201) | Singapore General Hospital | 2026-04-01 |
| Phase Ib/II Study of Polatuzumab Vedotin in Combination With Rituximab and Chidamide in Newly Diagnosed Elderly Patients With Double-Expressor DLBCL (NCT07415980) | Sun Yat-sen University | 2026-04-01 |
| QLS5132 Combination Therapy in Advanced Solid Tumors (NCT07453394) | Qilu Pharmaceutical Co., Ltd. | 2026-04-01 |
| Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma (NCT07523737) | Beijing Tongren Hospital | 2026-04-01 |
| Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled Study (NCT07539792) | Nanfang Hospital, Southern Medical University | 2026-04-01 |
| Mesenteric Vascular Preconditioning Combined With Laparoscopic and Endoscopic Cooperative Surgery for Submucosal Tumor at the Gastroesophageal Junction (NCT07550582) | Peking University People's Hospital | 2026-04-01 |